Federal Court to Decide Fate of Pradaxa Bleeding Lawsuits Next Month

The Pradaxa Resource Center is the Web’s largest source for information on Pradaxa research, side effects and legal news. Visit http://www.Pradaxa-lawsuits.org.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Pradaxa lawsuit
Quote startA federal court decision next month could improve their access to the courts and speed up the legal process.Quote end

Orlando, FL (PRWEB) June 20, 2012

The Pradaxa Resource Center, a patient advocacy group, is alerting patients who have suffered internal bleeding after taking the drug Pradaxa that a federal court decision next month could improve their access to the courts and speed up the legal process.

Anyone who has suffered internal bleeding or lost a loved one after taking Pradaxa is encouraged to speak with a lawyer about their legal rights as soon as possible.

Pradaxa is an anticoagulant medication prescribed to patients with atrial fibrillation in order to prevent strokes. The Wall Street Journal reported on April 24, 2012, that the drug already reached the $1 billion blockbuster sales mark for the 12-month period ending in February.

Unfortunately, other reports have identified risks with the drug. The FDA warned on December 7, 2011 that it was looking into the safety of Pradaxa after receiving higher than expected reports of injury or death. Most recently, the Institute for Safe Medication Practices reported on June 6, 2012 that Pradaxa led all other medications in 2011 for number of death and bleeding reports to the FDA.

Due to the number of lawsuits expected over Pradaxa bleeding injury or death, a motion to consolidate the cases into one central federal court was recently filed on May 30, 2012 in Case MDL No. 2385 IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. Now, the U.S. Judicial Panel on Multidistrict Litigation (JPML) has stated the issue will be decided on July 26, 2012.

The Pradaxa Resource Center believes that the consolidation of Pradaxa lawsuits into one court will expedite the litigation process and help victims share in valuable evidence. However, due to the specialized nature of these federal MDL cases, only certain lawyers can help.

Anyone affected by Pradaxa side effects is urged to speak with a lawyer about their legal options. The Pradaxa Resource center works only with lawyers who are already handling Pradaxa lawsuits.

For more information on the research, warnings, side effects and legal options relating to the drug Pradaxa, or to speak with a lawyer, visit http://www.Pradaxa-lawsuits.org.


Contact